Government Bureaucracy Getting in the Way of COVID Testing
11 September 2020
Phil Kerpen, President of American Commitment, discusses why COVID testing is failing, the value of making paper antigen tests readily available for use, and why it is beyond time for the FDA to get on board with at-home testing.
0:00 0:00

Related Podcasts

A Healthy Healthcare System Needs Less Government Intervention
14 May 2026
Jeremy Nighohossian, Senior Fellow and Economist at the Competitive Enterprise Institute, discusses positive developments in healthcare, including changes in drug development, what the resignation of FDA Commissioner Marty Makary may mean for healthcare policy, and why Certificate of Need (CON) laws impede free market competition and access to care.
The Trump Administration and Push for a Smaller, More Limited Government
30 January 2025
Phil Kerpen, Founder and President of American Commitment, discusses top of the agenda items for the new Trump Administration, how deregulation can drastically improve the lives of Americans and promote economic growth, and why the federal government should be firing and not hiring.
Politics Over Science? Why Did AAP Backtrack On Its Support of Schools Reopening During Covid?
24 October 2024
Phil Kerpen, President of American Commitment, discusses a recently filed lawsuit seeking emails on why the American Academy of Pediatrics backtracked in 2020 on supporting schools reopening in the fall of 2020, the role of the teachers unions, and the potential political motivation behind the reversal.
Government Should Not Be Picking Winners and Losers in Healthcare
28 June 2024
Lauren Stewart, Senior Federal Legislative Liaison at Americans for Prosperity and Concerned Veterans for America, discusses how President Biden is attempting to rewrite his record on healthcare, how his policies have resulted in limited access and increased costs for Americans, and how a personal option healthcare plan can provide more choices and more solutions.
Government Price Controls for Prescription Drugs Are Bad Medicine for Americans
28 June 2024
Sally Pipes, President and CEO of Pacific Research Institute, discusses how President Biden's price controls will result in prescription drug shortages and discourage innovation, how government mandates and regulations raise insurance costs, and the grim prognosis on Medicare and Medicaid's viability.
Reducing Government Bureaucracy will Reduce Healthcare Costs
10 March 2022
Dr. Diana M. Girnita, MD, PhD, CEO & Founder of Rheumatologist OnCall and a strong advocate for empowering physicians and patients to take charge of their medical health, discusses some of the serious challenges with America's healthcare system, why patients and their physicians should be allowed to assess the risks and make their own decisions free from government mandates, and how health savings accounts (HSAs) can further improve access to healthcare.